Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
doxorubicin (Doxil) (1 trial)
trastuzumab (herceptin) (1 trial)
methylprednisolone (medrol) (1 trial)
Brain Neoplasms (Phase 2)
Glioma (Phase 2)
Multiple Sclerosis (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms, Second Primary (Phase 2)
Sclerosis (Phase 1)
Trials (2 total)
Trial APIs (3 total)